MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6502-470-478$20.00
Mol Pharmacol 65:470-478, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mifflin, R. C.
Right arrow Articles by Powell, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mifflin, R. C.
Right arrow Articles by Powell, D. W.

Aspirin-Mediated COX-2 Transcript Stabilization via Sustained p38 Activation in Human Intestinal Myofibroblasts

Randy C. Mifflin, Jamal I. Saada, John F. Di Mari, John D. Valentich, Patrick A. Adegboyega, and Don W. Powell

Departments of Internal Medicine (R.C.M., J.I.S., J.F.D., J.D.V., D.W.P.), Pathology (P.A.A.), and Physiology and Biophysics (D.W.P.), The University of Texas Medical Branch, Galveston, Texas

Acetylsalicylic acid (aspirin) is a cyclooxygenase (COX) inhibitor, yet some of its therapeutic effects are thought to derive from mechanisms unrelated to prostaglandin synthesis inhibition. In human intestinal myofibroblasts, aspirin, at therapeutic doses, had the unexpected effect of inducing prolonged COX-2 expression. This induction was especially pronounced when cells were treated with interleukin-1{alpha} (IL-1) plus aspirin for 24 h. Sodium salicylate, a poor COX inhibitor, likewise enhanced IL-1–mediated COX-2 gene expression whereas 5-aminosalicylic acid (5-ASA) or indomethacin had no effect. The COX-2 transcriptional rate, measured by nuclear runoff analysis and heterogeneous nuclear RNA reverse transcription-polymerase chain reaction, was only modestly elevated by aspirin treatment. In contrast, aspirin treatment dramatically stabilized the COX-2 message. The COX-2 mRNA half-life in IL-1 treated cells was 1 h and was increased in excess of 5 h in IL-1 + aspirintreated cells. Phosphorylation of p38 MAPK was enhanced in aspirin-treated cells (but not in cells treated with 5-ASA or indomethacin) for up to 24 h after treatment. Inhibition of p38 activity negated aspirin-mediated COX-2 mRNA stabilization and the resultant increase in COX-2 mRNA and protein levels. The modest transcriptional response seen in aspirin treated cells was also abolished by p38 inhibition. We conclude that aspirin enhances COX-2 expression via sustained activation of p38, which results in prolonged stabilization of the COX-2 message and a slightly elevated transcription rate. Aspirin also enhanced steady-state mRNA levels of other IL-1 modulated genes (IL-1{beta}, IL-6, gro{alpha}, and TNF{alpha}) that are likewise regulated at the level of message stability via p38 activation.


Received June 9, 2003; accepted November 3, 2003

Address correspondence to: Randy C Mifflin, Department of Internal Medicine, Division of Gastroenterology, University of Texas Medical Branch, Galveston, TX 77555-1058. E-mail rmifflin{at}utmb.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Xu, C. M. Kitchen, H.-K. G. Shu, and T. J. Murphy
Platelet-derived Growth Factor-induced Stabilization of Cyclooxygenase 2 mRNA in Rat Smooth Muscle Cells Requires the c-Src Family of Protein-tyrosine Kinases
J. Biol. Chem., November 9, 2007; 282(45): 32699 - 32709.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Di Mari, J. I. Saada, R. C. Mifflin, J. D. Valentich, and D. W. Powell
HETEs enhance IL-1-mediated COX-2 expression via augmentation of message stability in human colonic myofibroblasts
Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G719 - G728.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Siegfried, C. T. Gubish, M. E. Rothstein, P. E. Q. de Oliveira, and L. P. Stabile
Signaling Pathways Involved in Cyclooxygenase-2 Induction by Hepatocyte Growth Factor in Non Small-Cell Lung Cancer
Mol. Pharmacol., September 1, 2007; 72(3): 769 - 779.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
C. R. Heier, R. G. Gogliotti, and C. J. DiDonato
SMN Transcript Stability: Could Modulation of Messenger RNA Degradation Provide a Novel Therapy for Spinal Muscular Atrophy?
J Child Neurol, August 1, 2007; 22(8): 1013 - 1018.
[Abstract] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. Peiris, I. Pacheco, C. Spencer, and R. J. MacLeod
The extracellular calcium-sensing receptor reciprocally regulates the secretion of BMP-2 and the BMP antagonist Noggin in colonic myofibroblasts
Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G753 - G766.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. C. Thoms, M. G. Dunlop, and L. A. Stark
p38-Mediated Inactivation of Cyclin D1/Cyclin-Dependent Kinase 4 Stimulates Nucleolar Translocation of RelA and Apoptosis in Colorectal Cancer Cells
Cancer Res., February 15, 2007; 67(4): 1660 - 1669.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. K. Kundu, Y. K. Shin, S. H. Kim, and Y.-J. Surh
Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-{kappa}B in mouse skin by blocking I{kappa}B kinase activity
Carcinogenesis, July 1, 2006; 27(7): 1465 - 1474.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kim, S. H. Rhee, E. Kokkotou, X. Na, T. Savidge, M. P. Moyer, C. Pothoulakis, and J. T. LaMont
Clostridium difficile Toxin A Regulates Inducible Cyclooxygenase-2 and Prostaglandin E2 Synthesis in Colonocytes via Reactive Oxygen Species and Activation of p38 MAPK
J. Biol. Chem., June 3, 2005; 280(22): 21237 - 21245.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics